Proposed diagnostic criteria for mild cognitive impairment in Down syndrome population.


Journal

Journal of applied research in intellectual disabilities : JARID
ISSN: 1468-3148
Titre abrégé: J Appl Res Intellect Disabil
Pays: England
ID NLM: 9613616

Informations de publication

Date de publication:
Mar 2022
Historique:
revised: 08 10 2021
received: 23 08 2020
accepted: 08 10 2021
pubmed: 26 10 2021
medline: 19 2 2022
entrez: 25 10 2021
Statut: ppublish

Résumé

Despite presenting higher risk of dementia, mild cognitive impairment (MCI) is not well defined in Down syndrome population. We aimed to describe cognitive and neuropsychological patterns associated with MCI in Down syndrome individuals. Two groups of adults with Down syndrome (control and prodromal) were studied throughout 3 years. Two linear mixed models and a model including the variables that best predicted group membership were built. Behavioural Regulation Index (BRI) (Behaviour Rating Inventory of Executive Function test) and the model composed of BRI, abstraction and delayed verbal memory were the variable and model best predicting group membership, respectively. Suggest a diagnosis of MCI when BRI is the earliest change perceived by caregivers and this is combined with low scores in abstract thinking, and when an amnesic pattern in delayed verbal memory is observed, but adaptive skills are preserved.

Sections du résumé

BACKGROUND BACKGROUND
Despite presenting higher risk of dementia, mild cognitive impairment (MCI) is not well defined in Down syndrome population.
OBJECTIVE OBJECTIVE
We aimed to describe cognitive and neuropsychological patterns associated with MCI in Down syndrome individuals.
METHOD METHODS
Two groups of adults with Down syndrome (control and prodromal) were studied throughout 3 years. Two linear mixed models and a model including the variables that best predicted group membership were built.
RESULTS RESULTS
Behavioural Regulation Index (BRI) (Behaviour Rating Inventory of Executive Function test) and the model composed of BRI, abstraction and delayed verbal memory were the variable and model best predicting group membership, respectively.
CONCLUSION CONCLUSIONS
Suggest a diagnosis of MCI when BRI is the earliest change perceived by caregivers and this is combined with low scores in abstract thinking, and when an amnesic pattern in delayed verbal memory is observed, but adaptive skills are preserved.

Identifiants

pubmed: 34693611
doi: 10.1111/jar.12959
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-505

Subventions

Organisme : Institute of Health Carlos III
ID : PI12/02019
Organisme : Ministry of Economy and Competitiveness

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7(3), 270-279. https://doi.org/10.1016/j.jalz.2011.03.008
American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
Arnaiz, E., & Almkvist, O. (2003). Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum, 179, 34-41.
Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000). Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs. Experimental Neurology, 163(1), 111-122. https://doi.org/10.1006/exnr.2000.7359
Baldo, J. V., Schwartz, S., Wilkins, D., & Dronkers, N. F. (2006). Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. Journal of the International Neuropsychological Society, 12(6), 896-900. https://doi.org/10.1017/s1355617706061078
Baldo, J. V., Shimamura, A. P., Delis, D. C., Kramer, J., & Kaplan, E. (2001). Verbal and design fluency in patients with frontal lobe lesions. Journal of the International Neuropsychological Society, 7(5), 586-596. https://doi.org/10.1017/s1355617701755063
Ball, S. L., Holland, A. J., Hon, J., Huppert, F. A., Treppner, P., & Watson, P. C. (2006). Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: Findings from a prospective population-based study. International Journal of Geriatric Psychiatry, 21(7), 661-673. https://doi.org/10.1002/gps.1545
Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016). Dementia in Down's syndrome. Lancet Neurology, 15(6), 622-636.
Bates, D., Machler, M., Bolker, B. M., & Walker, S. C. (2015). Fitting linear mixed-effects models using lme4. Journal of Statistical Software, 67(1), 1-48. https://doi.org/10.18637/jss.v067.i01
Chen, X. Q., Sawa, M., & Mobley, W. C. (2017). Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. Free Radical Biology & Medicine, 114, 52-61. https://doi.org/10.1016/j.freeradbiomed.2017.10.341
R Core Team (2020). R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria, https://www.R-project.org/.
Culbertson, W., & Zillmer, E. (2001). The tower of London-Drexel University. Multi-Health Systems.
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., Broich, K., Cavedo, E., Crutch, S., Dartigues, J.-F., Duyckaerts, C., Epelbaum, S., Frisoni, G. B., Gauthier, S., Genthon, R., … Jack, C. R. (2016). Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia. The Journal of the Alzheimer's Association, 12(3), 292-323. https://doi.org/10.1016/j.jalz.2016.02.002.Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA
Esteba-Castillo, S., Dalmau-Bueno, A., Ribas-Vidal, N., Vila-Alsina, M., Novell-Alsina, R., & Garcia-Alba, J. (2013). Adaptation and validation of CAMDEX-DS (Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities. Revista de Neurologia, 57(8), 337-346.
Esteba-Castillo, S., Pena-Casanova, J., Garcia-Alba, J., Castellanos, M. A., Torrents-Rodas, D., Rodriguez, E., Deus-Yela, J., Caixas, A., & Novell-Alsina, R. (2017). Barcelona test for intellectual disability: A new instrument for the neuropsychological assessment of adults with intellectual disability. Revista de Neurologia, 64(10), 433-444.
Fenoll, R., Pujol, J., Esteba-Castillo, S., de Sola, S., Ribas-Vidal, N., Garcia-Alba, J., Gonzalo, S.-B., Gerard, M.-V., Joan, D., Mara, D., Ramón, N.-A., & de la Torre, R. (2017). Anomalous white matter structure and the effect of age in Down syndrome patients. Journal of Alzheimers Disease, 57(1), 61-70. https://doi.org/10.3233/jad-161112
Firth, N. C., Startin, C. M., Hithersay, R., Hamburg, S., Wijeratne, P. A., Mok, K. Y., Hardy, J., Alexander, D. C., The LonDownS Consortium, & Strydom, A. (2018). Aging related cognitive changes associated with Alzheimer's disease in Down syndrome. Annals of Clinical & Translational Neurology, 5(6), 741-751. https://doi.org/10.1002/acn3.571
Fonseca, L. M., Mattar, G. P., Haddad, G. G., Goncalves, A. S., Miguel, A. D. C., Guilhoto, L. M., Zaman, S., Holland, A. J., de Campos Bottino, C. M., & Hoexter, M. Q. (2019). Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome. Neurobiology of Aging, 78, 186-194. https://doi.org/10.1016/j.neurobiolaging.2019.02.028
Fuld, P. A. (1980). Guaranteed stimulus-processing in the evaluation of memory and learning. Cortex, 16(2), 255-271. https://doi.org/10.1016/s0010-9452(80)80061-x
Garcia-Alba, J., Esteba-Castillo, S., Castellanos, M. A., Rodriguez, E., Ribas, N., Moldenhauer, F., & Novell-Alsina, R. (2017). Validation and normalization of the tower of London-Drexel University test 2nd edition in an adult population with intellectual disability. Spanish Journal of Psychology, 20, E32. https://doi.org/10.1017/sjp.2017.30
Garcia-Alba, J., Ramirez-Torano, F., Esteba-Castillo, S., Bruna, R., Moldenhauer, F., Novell, R., Medina, V. R., Maestu, F., & Fernandez, A. (2019). Neuropsychological and neurophysiological characterization of mild cognitive impairment and Alzheimer's disease in Down syndrome. Neurobiology of Aging, 84, 70-79. https://doi.org/10.1016/j.neurobiolaging.2019.07.017
Geda, Y. E., & Nedelska, Z. (2012). Mild cognitive impairment: A subset of minor neurocognitive disorder? American Journal of Geriatric Psychiatry, 20(10), 821-826. https://doi.org/10.1097/JGP.0b013e31826abc00
Gioia, G. A., Isquith, P. K. G., Steven, C., & Kenworthy, L. (2000). Behavior rating inventory of executive function. Psychological Assessment Resources, Inc.
Goldstein, K., & Scheerer, M. (1941). Abstract and concrete behavior an experimental study with special tests. Psychological Monographs, 53, i-151.
Hartley, S. L., Handen, B. L., Devenny, D., Tudorascu, D., Piro-Gambetti, B., Zammit, M. D., Laymon, C. M., Klunk, W. E., Zaman, S., Cohen, A., & Christian, B. T. (2020). Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome. Alzheimer's & dementia (Amsterdam, Netherlands), 12(1), e12096. https://doi.org/10.1002/dad2.12096
Holland, A. J., Hon, J., Huppert, F. A., Stevens, F., & Watson, P. (1998). Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. British Journal of Psychiatry, 172, 493-498. https://doi.org/10.1192/bjp.172.6.493
Jack, C. R., Jr., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., … Silverberg, N. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & dementia: The journal of the Alzheimer's Association, 14(4), 535-562. https://doi.org/10.1016/j.jalz.2018.02.018
Kaufman, A. S., & Kaufman, N. L. (2004). Kaufman brief intelligence test (2nd ed.). American Guidance Service.
Lott, I. T. (2012). Neurological phenotypes for Down syndrome across the life span. Progress in Brain Research, 197, 101-121. https://doi.org/10.1016/b978-0-444-54299-1.00006-6
Lott, I. T., & Head, E. (2019). Dementia in Down syndrome: Unique insights for Alzheimer disease research. Nature Reviews Neurology, 15(3), 135-147. https://doi.org/10.1038/s41582-018-0132-6
Moreno-Jimenez, E. P., Flor-Garcia, M., Terreros-Roncal, J., Rabano, A., Cafini, F., Pallas-Bazarra, N., Avila, J., & Llorens-Martin, M. (2019). Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease. Nature Medicine, 25(4), 554-560. https://doi.org/10.1038/s41591-019-0375-9
Moss, S., Ibbotson, B., Prosser, H., Goldberg, D., Patel, P., & Simpson, N. (1997). Validity of the PAS-ADD for detecting psychiatric symptoms in adults with learning disability (mental retardation). Social Psychiatry and Psychiatric Epidemiology, 32(6), 344-354. https://doi.org/10.1007/BF00805440
Mullins, D., Daly, E., Simmons, A., Beacher, F., Foy, C. M., Lovestone, S., Hallahan, B., Murphy, K. C., & Murphy, D. G. (2013). Dementia in Down's syndrome: An MRI comparison with Alzheimer's disease in the general population. Journal of Neurodevelopmental Disorders, 5(1), 19. https://doi.org/10.1186/1866-1955-5-19
Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J. M. S., Rowland, L. M., Workman, C. I., & Smith, G. S. (2019). Neurometabolites and associations with cognitive deficits in mild cognitive impairment: A magnetic resonance spectroscopy study at 7 tesla. Neurobiology of Aging, 73, 211-218. https://doi.org/10.1016/j.neurobiolaging.2018.09.027
Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183-194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
Petersen, R. C. (2011). Clinical practice. Mild cognitive impairment. New England Journal of Medicine, 364(23), 2227-2234. https://doi.org/10.1056/NEJMcp0910237
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303-308.
Pujol, J., Fenoll, R., Ribas-Vidal, N., Martínez-Vilavella, G., Blanco-Hinojo, L., García-Alba, J., Deus, J., Novell, R., & Esteba-Castillo, S. (2018). A longitudinal study of brain anatomy changes preceding dementia in Down syndrome. NeuroImage: Clinical, 18, 160-166. https://doi.org/10.1016/j.nicl.2018.01.024
Rabin, L. A., Pare, N., Saykin, A. J., Brown, M. J., Wishart, H. A., Flashman, L. A., & Santulli, R. B. (2009). Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychology, development, and cognition. Section B. Aging, Neuropsychology and Cognition, 16(3), 357-376. https://doi.org/10.1080/13825580902825220
Rainville, C., Lepage, E., Gauthier, S., Kergoat, M. J., & Belleville, S. (2012). Executive function deficits in persons with mild cognitive impairment: A study with a tower of London task. Journal of Clinical Experimental Neuropsychology, 34(3), 306-324. https://doi.org/10.1080/13803395.2011.639298
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J. C., & Muller, M. (2011). pROC: An open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinformatics, 12. https://doi.org/10.1186/1471-2105-12-77
Rozencwajg, R., & Bertoux, L. (2008). Categorization and aging as measured by an adapted version of Weschler's similarities test. Current psychology letters. Behaviour Brain & Cognition, 2(24), 82-97.
Rubenstein, E., Hartley, S., & Bishop, L. (2020). Epidemiology of dementia and Alzheimer disease in individuals with Down syndrome. JAMA Neurology, 77(2), 262-264. https://doi.org/10.1001/jamaneurol.2019.3666
Shallice, T., & Burgess, P. W. (1991). Deficit in strategy application following frontal-lobe damage in man. Brain, 114, 727-741. https://doi.org/10.1093/brain/114.2.727
Sheehan, R., Sinai, A., Bass, N., Blatchford, P., Bohnen, I., Bonell, S., Courtenay, K., Hassiotis, A., Markar, T., McCarthy, J., Mukherji, K., Naeem, A., Paschos, D., Perez-Achiaga, N., Sharma, V., Thomas, D., Walker, Z., & Strydom, A. (2015). Dementia diagnostic criteria in Down syndrome. International Journal of Geriatric Psychiatry, 30(8), 857-863. https://doi.org/10.1002/gps.4228
Sinai, A., Mokrysz, C., Bernal, J., Bohnen, I., Bonell, S., Courtenay, K., Dodd, K., Gazizova, D., Hassiotis, A., Hillier, R., McBrien, J., McCarthy, J., Mukherji, K., Naeem, A., Perez-Achiaga, N., Rantell, K., Sharma, V., Thomas, D., Walker, Z., … Strydom, A. (2018). Predictors of age of diagnosis and survival of Alzheimer's disease in Down syndrome. Journal of Alzheimers Disease, 61(2), 717-728. https://doi.org/10.3233/jad-170624
Sparrow, S. S., Cicchetti, D. V., & Balla, D. A. (2008). Vineland adaptive behavior scales: Second edition (Vineland II), the expanded interview form. Pearson Assessments.
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Jr., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., … Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7(3), 280-292. https://doi.org/10.1016/j.jalz.2011.03.003
Startin, C. M., Hamburg, S., Hithersay, R., Al-Janabi, T., Mok, K. Y., Hardy, J., LonDownS Consortium, & Strydom, A. (2019). Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 15(2), 245-257. https://doi.org/10.1016/j.jalz.2018.08.009
Vaughan, R. M., Coen, R. F., Kenny, R., & Lawlor, B. A. (2016). Preservation of the semantic verbal fluency advantage in a large population-based sample: Normative data from the TILDA study. Journal of International Neuropsychological Society, 22(5), 570-576. https://doi.org/10.1017/s1355617716000291

Auteurs

Susanna Esteba-Castillo (S)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Girona, Spain.

Javier Garcia-Alba (J)

Research and Psychology in Education Department (Faculty of Education), Complutense University of Madrid, Madrid, Spain.

Emili Rodríguez-Hildago (E)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Girona, Spain.

Lucía Vaquero (L)

Laboratory of Cognitive and Computational Neuroscience, Department of Legal Medicine, Psychiatry and Pathology (Faculty of Medicine), Complutense University of Madrid, Madrid, Spain.

Ramon Novell (R)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Girona, Spain.

Fernando Moldenhauer (F)

Adults' Section of the Down syndrome Department, Internal Medicine Department, La Princesa University Hospital, Madrid, Spain.

Miguel Ángel Castellanos (MÁ)

Department of Methodology for Behavioral Science, Complutense University of Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH